Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer

Thumbnail Image
e016133.full.pdf (4.92 MB)
Identifiers
URI: https://hdl.handle.net/10641/8369
ISSN: 2051-1426
DOI: 10.1136/jitc-2026-016133

Publication date

2026-09-10

Start date of the public exhibition period

End date of the public exhibition period

Authors

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Share
Export

Research Projects

Organizational Units

Journal Issue

Doctoral program

Description

Publisher Copyright: © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.

Keywords

Lung Cancer, Neoadjuvant, Tumor Microenvironment, co-stimulatory molecules, Immunology and Allergy, Immunology, Molecular Medicine, Oncology, Pharmacology, Cancer Research, SDG 3 - Good Health and Well-being, Yes

Citation

Fernández-Luna, C, Baena, J, Calles, A, Antoñanzas-Basa, M, Lage Alfranca, Y, Mielgo, X, Sereno, M, Cervera, R, Cabezon-Gutierrez, L, López, A, Rubio, J, Conde, E, Lopez-Rios, F, Alvarez-Vallina, L, Valencia, K, Montuenga, L M, Ruiz De Garibay, G, Molero, M, Adradas, V, Curto-Aguilera, D, Peressini, M, Carrera-Elvira, E, Ballesteros, D, Portillo-Fernández, A, Lopez-Cárdenas, T, Serrano-Gómez, C, Bote, H, Torres-Jiménez, J, Cruz-Bermúdez, A, Provencio, M, Paz-Ares, L, Sánchez-Herrero, E & Zugazagoitia, J 2026, 'Tumor cell-expressed OX40L enhances the efficacy of PD-1 axis blockade in non-small cell lung cancer', Journal for immunotherapy of cancer, vol. 14, no. 9, e016133. https://doi.org/10.1136/jitc-2026-016133

Collections

FACULTAD DE MEDICINA